Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Disease-2019”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Testing effectiveness (Phase 2)Study completedNCT04481685
What this trial is testing

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
University of Kansas Medical Center 20
Early research (Phase 1)Study completedNCT04519437
What this trial is testing

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 974
Not applicableStudy completedNCT04885777
What this trial is testing

Topical Lidocaine Anesthesia for Nasopharyngeal Sampling

Who this might be right for
Nasopharyngeal SamplingLocal Anesthesia
Ataturk University 50
Not applicableStudy completedNCT04403009
What this trial is testing

The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19

Who this might be right for
Coronavirus Disease 2019Character of the Severe Patients
The First Affiliated Hospital of Guangzhou Medical University 100
Not applicableStudy completedNCT04452604
What this trial is testing

Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19

Who this might be right for
Acute Myeloblastic LeukemiaAcute Lymphoblastic LeukemiaSARS-CoV-2
French Innovative Leukemia Organisation 79
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512
Early research (Phase 1)Study completedNCT05505448
What this trial is testing

A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

Who this might be right for
Healthy
Regeneron Pharmaceuticals 48
Testing effectiveness (Phase 2)Ended earlyNCT04511650
What this trial is testing

Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019

Who this might be right for
COVID-19Acute Respiratory Distress Syndrome (ARDS)
EyePoint Pharmaceuticals, Inc. 31
Post-approval studies (Phase 4)Active Not RecruitingNCT07266558
What this trial is testing

Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,000
Not applicableUnknownNCT04367350
What this trial is testing

Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement

Who this might be right for
COVIDSars-CoV2Corona Virus Infection+2 more
University Hospital Tuebingen 500
Large-scale testing (Phase 3)Study completedNCT05007678
What this trial is testing

Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease

Who this might be right for
COVID-19
Ashford and St. Peter's Hospitals NHS Trust 178
Not applicableStudy completedNCT04379310
What this trial is testing

Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)

Who this might be right for
Covid-19
Istanbul Nisantasi University 54
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Not applicableStudy completedNCT04430023
What this trial is testing

Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia

Who this might be right for
Corona Virus InfectionPneumoniaAcute Respiratory Failure
Sisli Hamidiye Etfal Training and Research Hospital 150
Large-scale testing (Phase 3)Study completedNCT05449405
What this trial is testing

Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I

Who this might be right for
COVID-19Symptoms and SignsCOVID-19 Pandemic+2 more
Dr. Ferrer BioPharma 101
Not applicableStudy completedNCT04799691
What this trial is testing

Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia

Who this might be right for
COVID-19
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 133
Not applicableUnknownNCT04867161
What this trial is testing

Superinfection and Hyperinflammatory Phenotype in COVID-19 (Coronavirus Disease 2019) Pneumonia Patients

Who this might be right for
COVID-19 PneumoniaSuperinfection Lung
Brno University Hospital 300
Not applicableStudy completedNCT07435805
What this trial is testing

Long-Term Health Effects of Previous Coronavirus Disease 2019 (COVID-19) in Patients Undergoing Preoperative Anesthesia Evaluation

Who this might be right for
Post-COVID ConditionLong COVIDSequelae of COVID-19
Elazıg Fethi Sekin Sehir Hastanesi 400
Post-approval studies (Phase 4)Ended earlyNCT04346667
What this trial is testing

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

Who this might be right for
SARS-CoV-2Coronavirus InfectionAsymptomatic Condition+1 more
Government of Punjab, Specialized Healthcare and Medical Education Department 125
Next Page